tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

RNA Stock Latest News

Avidity, Phathom mentioned as potential takeout targets at Needham
The FlyAvidity, Phathom mentioned as potential takeout targets at Needham
22h ago
BMY
NVO
Avidity Biosciences Positioned for Leadership in Muscular Dystrophy with Strategic Regulatory Advancements
PremiumRatings
Avidity Biosciences Positioned for Leadership in Muscular Dystrophy with Strategic Regulatory Advancements
3d ago
RNA
Raymond James Predicts Up to ~760% Surge for These 2 ‘Strong Buy’ Stocks
PremiumStock Analysis & Ideas
Raymond James Predicts Up to ~760% Surge for These 2 ‘Strong Buy’ Stocks
6d ago
RNA
ACHV
Avidity Biosciences price target raised to $70 from $60 at Evercore ISI
PremiumThe Fly
Avidity Biosciences price target raised to $70 from $60 at Evercore ISI
7d ago
RNA
Avidity Biosciences: Promising Advancements and Strategic Positioning Drive Buy Rating
PremiumRatings
Avidity Biosciences: Promising Advancements and Strategic Positioning Drive Buy Rating
7d ago
RNA
Avidity Biosciences resumed with a Buy at Goldman Sachs
PremiumThe FlyAvidity Biosciences resumed with a Buy at Goldman Sachs
8d ago
RNA
Avidity Biosciences’ Promising Phase 3 Study on FSHD Treatment: Market Implications
Premium
Company Announcements
Avidity Biosciences’ Promising Phase 3 Study on FSHD Treatment: Market Implications
22d ago
RNA
Lyft upgraded, Block assumed: Wall Street’s top analyst calls
Premium
The Fly
Lyft upgraded, Block assumed: Wall Street’s top analyst calls
24d ago
EA
RH
Avidity Biosciences initiated with an Outperform at Bernstein
PremiumThe Fly
Avidity Biosciences initiated with an Outperform at Bernstein
24d ago
RNA
Avidity, BridgeBio, Coty, SAGE, Alkermes: Trending by Analysts
PremiumWeekend Updates
Avidity, BridgeBio, Coty, SAGE, Alkermes: Trending by Analysts
27d ago
RNA
ALKS
Avidity Biosciences: Strong Market Position and Future Potential Justify Buy Rating
PremiumRatings
Avidity Biosciences: Strong Market Position and Future Potential Justify Buy Rating
1M ago
RNA
Avidity Biosciences Positioned for Market Leadership with Promising DM1 Treatment in Phase 3 Trial
PremiumRatings
Avidity Biosciences Positioned for Market Leadership with Promising DM1 Treatment in Phase 3 Trial
1M ago
RNA
Avidity Biosciences initiated with an Outperform at Wolfe Research
PremiumThe FlyAvidity Biosciences initiated with an Outperform at Wolfe Research
1M ago
RNA
Avidity Biosciences initiated with an Outperform at Wolfe Research
Premium
The Fly
Avidity Biosciences initiated with an Outperform at Wolfe Research
1M ago
RNA
Promising Developments in Avidity Biosciences’ FSHD Program Justify Buy Rating
Premium
Ratings
Promising Developments in Avidity Biosciences’ FSHD Program Justify Buy Rating
1M ago
RNA
Avidity Biosciences initiated with a Strong Buy at Raymond James
PremiumThe Fly
Avidity Biosciences initiated with a Strong Buy at Raymond James
1M ago
RNA
Avidity Biosciences Holds 2025 Annual Stockholder Meeting
PremiumCompany Announcements
Avidity Biosciences Holds 2025 Annual Stockholder Meeting
1M ago
8K
RNA
Avidity Biosciences: Promising Developments and FDA Endorsement Position for Potential Regulatory Approvals by 2027
PremiumRatings
Avidity Biosciences: Promising Developments and FDA Endorsement Position for Potential Regulatory Approvals by 2027
1M ago
RNA
Avidity Biosciences price target raised to $75 from $70 at Citi
PremiumThe Fly
Avidity Biosciences price target raised to $75 from $70 at Citi
1M ago
RNA
Avidity Biosciences price target raised to $59 from $57 at Barclays
PremiumThe FlyAvidity Biosciences price target raised to $59 from $57 at Barclays
1M ago
RNA
Avidity data strengthens accelerated approval case, says H.C. Wainwright
Premium
The Fly
Avidity data strengthens accelerated approval case, says H.C. Wainwright
1M ago
RNA
Avidity Biosciences price target raised to $65 from $60 at Leerink
Premium
The Fly
Avidity Biosciences price target raised to $65 from $60 at Leerink
1M ago
RNA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >